IMIPENEM(CAS: 85960-17-4)

Imipenem (CAS: 85960-17-4) is classified as a beta-lactam antibiotic and is regulated under several guidelines. In the EU, it falls under the Reach and Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulations. In the US, the FDA regulates its manufacturing and distribution. Additionally, it must comply with EPA regulations for environmental protection and safe handling.

There are several alternatives to imipenem in synthesis, including other beta-lactam antibiotics like meropenem and doripenem. Other substitutes include non-beta-lactam alternatives such as carbapenems and cephalosporins. These alternatives are often used based on the specific properties required for the synthesis process.

The market for imipenem (CAS: 85960-17-4) is stable due to its broad-spectrum antibacterial properties. Research trends focus on understanding its mechanism of action, developing combination therapies, and exploring its use in multidrug-resistant infections. Market dynamics show a steady demand, with ongoing efforts to enhance its efficacy and reduce resistance.

Waste containing imipenem (CAS: 85960-17-4) should be collected in appropriate containers and disposed of through professional waste disposal services to ensure compliance with environmental regulations. Incineration is a common method, but it must be done in an environmentally controlled incinerator. Proper handling includes ensuring that waste is labeled correctly and stored in a secure, non-leaking container until disposal.